vs
Side-by-side financial comparison of ORTHOPEDIATRICS CORP (KIDS) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.
ORTHOPEDIATRICS CORP is the larger business by last-quarter revenue ($61.6M vs $41.8M, roughly 1.5× Neuronetics, Inc.). ORTHOPEDIATRICS CORP runs the higher net margin — -16.4% vs -17.2%, a 0.8% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 17.0%). ORTHOPEDIATRICS CORP produced more free cash flow last quarter ($9.7M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 17.4%).
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
KIDS vs STIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.6M | $41.8M |
| Net Profit | $-10.1M | $-7.2M |
| Gross Margin | 73.2% | 52.0% |
| Operating Margin | -13.3% | -12.1% |
| Net Margin | -16.4% | -17.2% |
| Revenue YoY | 17.0% | 85.7% |
| Net Profit YoY | 37.1% | 43.2% |
| EPS (diluted) | $-0.43 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.6M | $41.8M | ||
| Q3 25 | $61.3M | $37.3M | ||
| Q2 25 | $61.1M | $38.1M | ||
| Q1 25 | $52.4M | $32.0M | ||
| Q4 24 | $52.7M | $22.5M | ||
| Q3 24 | $54.6M | $18.5M | ||
| Q2 24 | $52.8M | $16.4M | ||
| Q1 24 | $44.7M | $17.4M |
| Q4 25 | $-10.1M | $-7.2M | ||
| Q3 25 | $-11.8M | $-9.0M | ||
| Q2 25 | $-7.1M | $-10.1M | ||
| Q1 25 | $-10.7M | $-12.7M | ||
| Q4 24 | $-16.1M | $-12.7M | ||
| Q3 24 | $-7.9M | $-13.3M | ||
| Q2 24 | $-6.0M | $-9.8M | ||
| Q1 24 | $-7.8M | $-7.9M |
| Q4 25 | 73.2% | 52.0% | ||
| Q3 25 | 73.9% | 45.9% | ||
| Q2 25 | 72.1% | 46.6% | ||
| Q1 25 | 73.0% | 49.2% | ||
| Q4 24 | 67.5% | 66.2% | ||
| Q3 24 | 73.4% | 75.6% | ||
| Q2 24 | 77.3% | 74.0% | ||
| Q1 24 | 72.0% | 75.1% |
| Q4 25 | -13.3% | -12.1% | ||
| Q3 25 | -15.4% | -19.6% | ||
| Q2 25 | -17.4% | -21.1% | ||
| Q1 25 | -21.0% | -34.4% | ||
| Q4 24 | -26.7% | -51.0% | ||
| Q3 24 | -10.2% | -41.7% | ||
| Q2 24 | -10.7% | -51.7% | ||
| Q1 24 | -21.8% | -39.4% |
| Q4 25 | -16.4% | -17.2% | ||
| Q3 25 | -19.2% | -24.3% | ||
| Q2 25 | -11.6% | -26.6% | ||
| Q1 25 | -20.3% | -39.6% | ||
| Q4 24 | -30.5% | -56.4% | ||
| Q3 24 | -14.5% | -72.0% | ||
| Q2 24 | -11.4% | -59.8% | ||
| Q1 24 | -17.5% | -45.2% |
| Q4 25 | $-0.43 | $-0.10 | ||
| Q3 25 | $-0.50 | $-0.13 | ||
| Q2 25 | $-0.30 | $-0.15 | ||
| Q1 25 | $-0.46 | $-0.21 | ||
| Q4 24 | $-0.70 | $-0.34 | ||
| Q3 24 | $-0.34 | $-0.44 | ||
| Q2 24 | $-0.26 | $-0.33 | ||
| Q1 24 | $-0.34 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.9M | $28.1M |
| Total DebtLower is stronger | $106.0M | $65.8M |
| Stockholders' EquityBook value | $346.6M | $22.4M |
| Total Assets | $508.6M | $141.6M |
| Debt / EquityLower = less leverage | 0.31× | 2.94× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.9M | $28.1M | ||
| Q3 25 | $57.7M | $28.0M | ||
| Q2 25 | $70.1M | $11.0M | ||
| Q1 25 | $58.8M | $20.2M | ||
| Q4 24 | $68.8M | $18.5M | ||
| Q3 24 | $76.1M | $20.9M | ||
| Q2 24 | $28.9M | $42.6M | ||
| Q1 24 | $47.7M | $47.7M |
| Q4 25 | $106.0M | $65.8M | ||
| Q3 25 | $105.3M | $65.7M | ||
| Q2 25 | $102.7M | $55.5M | ||
| Q1 25 | $77.4M | $55.3M | ||
| Q4 24 | $77.5M | $55.2M | ||
| Q3 24 | $76.9M | $46.0M | ||
| Q2 24 | $11.2M | $59.8M | ||
| Q1 24 | $11.3M | $59.4M |
| Q4 25 | $346.6M | $22.4M | ||
| Q3 25 | $349.3M | $27.4M | ||
| Q2 25 | $355.5M | $27.1M | ||
| Q1 25 | $347.1M | $35.5M | ||
| Q4 24 | $354.6M | $27.7M | ||
| Q3 24 | $370.9M | $9.4M | ||
| Q2 24 | $371.3M | $19.4M | ||
| Q1 24 | $370.6M | $27.7M |
| Q4 25 | $508.6M | $141.6M | ||
| Q3 25 | $493.5M | $145.5M | ||
| Q2 25 | $503.6M | $134.7M | ||
| Q1 25 | $470.3M | $142.0M | ||
| Q4 24 | $473.2M | $140.9M | ||
| Q3 24 | $489.3M | — | ||
| Q2 24 | $430.8M | $96.8M | ||
| Q1 24 | $437.2M | $103.8M |
| Q4 25 | 0.31× | 2.94× | ||
| Q3 25 | 0.30× | 2.40× | ||
| Q2 25 | 0.29× | 2.05× | ||
| Q1 25 | 0.22× | 1.56× | ||
| Q4 24 | 0.22× | 1.99× | ||
| Q3 24 | 0.21× | 4.90× | ||
| Q2 24 | 0.03× | 3.08× | ||
| Q1 24 | 0.03× | 2.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.3M | $908.0K |
| Free Cash FlowOCF − Capex | $9.7M | $692.0K |
| FCF MarginFCF / Revenue | 15.8% | 1.7% |
| Capex IntensityCapex / Revenue | 1.0% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.0M | $-21.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.3M | $908.0K | ||
| Q3 25 | $-581.0K | $-785.0K | ||
| Q2 25 | $-10.5M | $-3.5M | ||
| Q1 25 | $-4.2M | $-17.0M | ||
| Q4 24 | $-4.0M | $-8.6M | ||
| Q3 24 | $-10.3M | $-5.4M | ||
| Q2 24 | $-6.1M | $-5.0M | ||
| Q1 24 | $-6.7M | $-12.0M |
| Q4 25 | $9.7M | $692.0K | ||
| Q3 25 | $-3.4M | $-899.0K | ||
| Q2 25 | $-13.9M | $-3.8M | ||
| Q1 25 | $-8.4M | $-17.2M | ||
| Q4 24 | $-4.2M | $-8.7M | ||
| Q3 24 | $-11.7M | $-5.8M | ||
| Q2 24 | $-12.8M | $-5.6M | ||
| Q1 24 | $-13.2M | $-12.4M |
| Q4 25 | 15.8% | 1.7% | ||
| Q3 25 | -5.6% | -2.4% | ||
| Q2 25 | -22.8% | -9.9% | ||
| Q1 25 | -16.0% | -53.8% | ||
| Q4 24 | -8.1% | -38.6% | ||
| Q3 24 | -21.4% | -31.3% | ||
| Q2 24 | -24.2% | -34.0% | ||
| Q1 24 | -29.4% | -71.1% |
| Q4 25 | 1.0% | 0.5% | ||
| Q3 25 | 4.6% | 0.3% | ||
| Q2 25 | 5.6% | 0.7% | ||
| Q1 25 | 8.1% | 0.7% | ||
| Q4 24 | 0.5% | 0.4% | ||
| Q3 24 | 2.5% | 2.1% | ||
| Q2 24 | 12.7% | 3.7% | ||
| Q1 24 | 14.5% | 2.2% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
